Swiss drugmaker Roche to invest $50bn in US in effort to dodge Trump tariffsRoche invests $50bn in US manufacturing to create jobs and counter potential tariffs.
Biotech companies shed hundreds of Bay Area jobs in fresh layoffsBay Area biotech sector is experiencing significant layoffs, with life sciences companies cutting 310 jobs.
Roche's momentum in digital pathology continues with FDA clearance on its high-volume slide scannerRoche's VENTANA DP 600 slide scanner received FDA clearance for aiding clinical diagnosis with digital images.